Ulixertinib Uses, Dosage, Side Effects and more
Ulixertinib is a a novel, reversible, ATP-competitive ERK1/2 inhibitor with high potency and ERK1/2 selectivity . It is currently in clinical trials for the treatment of a wide range of tumors.
| Trade Name | Ulixertinib |
| Generic | Ulixertinib |
| Ulixertinib Other Names | Ulixertinib |
| Type | |
| Formula | C21H22Cl2N4O2 |
| Weight | Average: 433.33 Monoisotopic: 432.1119814 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
